← Eichor
Study identifier: NCT00912041 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

Condition: Tetraplegia · Spinal Cord Injuries · Amyotrophic Lateral Sclerosis  ·  Sponsor: Leigh R. Hochberg, MD, PhD.

PhaseNA
Planned participants27
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.

This description comes directly from the study's public registry record.

Talk to the study team

Leigh R Hochberg, M.D., Ph.D.  ·  617-724-9247  ·  clinicaltrials@braingate.org

Always discuss trial participation with your own doctor first.

Locations (6)

University of California, DavisSacramento, California, United StatesRecruiting
Stanford University School of MedicineStanford, California, United StatesRecruiting
Emory University School of MedicineAtlanta, Georgia, United StatesRecruiting
Massachusetts General HospitalBoston, Massachusetts, United StatesRecruiting
Providence VA Medical CenterProvidence, Rhode Island, United StatesRecruiting
Baylor College of MedicineHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT00912041